TS
MRK icon

Triglav Skladi’s Merck MRK Stock Holding History

Triglav Skladi’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.2M Buy
192,688
+57,869
+43% +$6.68M 1.62% 17
2025
Q4 		$14.2M Buy
134,819
+691
+0.5% +$64.9K 0.9% 23
2025
Q3 		$11.3M Buy
134,128
+46,410
+53% +$3.82M 0.74% 30
2025
Q2 		$6.94M Buy
87,718
+2,410
+3% +$192K 0.5% 42
2025
Q1 		$7.65M Sell
85,308
-2,363
-3% -$221K 0.64% 41
2024
Q4 		$8.72M Buy
+87,671
New +$9.04M 0.69% 33

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Triglav Skladi's MRK Position: Q1 2026 in Review

Triglav Skladi increased its Merck (MRK) stake by 43% in Q1 2026, buying an estimated $6.68M and bringing the position to 192,688 shares worth $23.2M. The position accounts for 1.62% of the portfolio, ranked #17.

Triglav Skladi first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Triglav Skladi held 192,688 shares of Merck worth $23.2M as of Q1 2026.
  • Triglav Skladi bought 57,869 Merck shares in Q1 2026, an estimated $6.68M.
  • Merck made up 1.62% of Triglav Skladi's portfolio in Q1 2026, its #17 holding.
  • Triglav Skladi first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Triglav Skladi's 13F filing for Q1 2026, filed 4 May 2026.